Close Menu

NEW YORK – Berkeley Lights reported on Tuesday a 10 percent decrease in second quarter revenues.

For the three months ended June 30, 2020, the Emeryville, California-based cell analysis firm reported $10.6 million in revenues, down from $11.8 million during the same period last year. Product revenues grew 17 percent to $9.1 million, while service revenue fell 63 percent to $1.5 million.

Milestone and related revenues were $128,000, compared to $3.2 million a year ago.

The firm placed four of its optofluidic platforms in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.